Moderate riskFDA DeviceClass II

RayStation 2023B planning software recalled for potential dose loss

RaySearch Laboratories AB is recalling RayStation 2023B, a radiation therapy treatment planning system, build 14.0.0.3338. When a deformable registration expands outward near the edge of the original dose grid, the clinically relevant dose may be deformed and possibly lost. The FDA classifies this as Class II, and no injuries have been reported.

From the FDA notice · Read the official notice ↗ · All Raysearch Laboratories recalls

What to do

  1. Check whether your system runs RayStation 2023B build 14.0.0.3338 (UDI 0735000201055620230630, GTIN 07350002010556).
  2. Review deformable registrations on this build for dose near the boundary of the original dose grid before relying on them.
  3. The notice does not specify a remedy; contact RaySearch Laboratories AB for next steps.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
RayStation 2023B. Model/Build Number: 14.0.0.3338. Radiation Therapy Treatment Planning System
Sold in
Nationwide
Made for
All ages (0 months and older)

This recall covers 9 products — see all of them.

Details

Units affected
61 units
Illnesses reported
None reported
Manufactured in
Eugeniavagen 18c, Stockholm, Sweden
Classification
Class II
Recall number
Z-0490-2027

In the FDA's words

Description
RayStation 2023B. Model/Build Number: 14.0.0.3338. Radiation Therapy Treatment Planning System Potential for dose deformation after using a deformable registration that expands outwards near the boundary of the original dose grid, possibly causing the clinically relevant dose to be lost. Model/Build Number: 14.0.0.3338. UDI: 0735000201055620230630. GTIN: 07350002010556. Serial Numbers: 14.0.0.3338. Software Revision: RayStation 2023B. Expiration Date: 2028-07-07. Distribution: Worldwide - US Nationwide distribution. Affected quantity: 61 units
Hazard
Potential for dose deformation after using a deformable registration that expands outwards near the boundary of the original dose grid, possibly causing the clinically relevant dose to be lost.

9 products in this recall

RayStation software recalled for potential dose deformation

RaySearch Laboratories is recalling 9 product entries of its RayStation radiation therapy treatment planning software, from RayStation 6.1.1 through RayStation 2024A SP3, distributed nationwide in the US. The agency says a deformable registration that expands outward near the boundary of the original dose grid may deform the dose, possibly causing the clinically relevant dose to be lost. The notice reports no injuries.

The agency lists each product separately. Check every one you might have.

Related topics